Changes in Healthcare Costs during the Obama Administration: What Happened to Spending by Businesses and Consumers

Dec 30, 2016 | Compliance, Legal, and Malpractice, Laboratory News, Laboratory Operations, Laboratory Pathology, Managed Care Contracts & Payer Reimbursement

In this second installment of a two-part briefing, the impact of the Affordable Care Act on healthcare spending by businesses and consumers during the past eight years is assessed No single piece of legislation during the Obama Administration generated more controversy than the Affordable Care Act (ACA), which became law in 2010. It was touted by proponents within and without the administration as the needed solution to the nation’s healthcare problems. The two biggest problems with healthcare...

Stanford’s New Ant-sized Radio Could Accelerate Massive Connectivity through the Internet of Things and Enable Real-time Medical Laboratory Testing

May 18, 2015 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing

Micro-miniature intelligent radio devices are poised to revolutionize the connectivity of objects in ways that could open doors to new diagnostic devices to help pathologists detect disease In the future, both in vitro diagnostics and in vivo diagnostics will utilize ever-smaller devices. The shrinking size of these analytical devices will give pathologists and clinical laboratory scientists new tools to detect disease earlier, while monitoring patient with chronic conditions in real-time in...

Illumina Is Using Acquisitions to Challenge Roche in Fast-growing Market for Gene-based Clinical Pathology Laboratory Testing

Nov 23, 2012 | Laboratory Hiring & Human Resources, Laboratory News, Laboratory Pathology

Hot competition for genetic testing market share is a signal to medical laboratories to ramp up their molecular and genetic testing capabilities Financial analysts see something of an “old west” style shootout on the horizon for genetic testing in the clinical laboratory testing market. Market leaders in next-generation gene sequencing are prepared to use acquisitions to build dominant shares in a gene testing market that experts say could hit $25 billion by 2022. Reporters at Bloomberg...

FDA Issues Proposed Rule on Medical Device UDI System That Will Also Apply to Clinical Pathology Analyzers and Lab Products

Sep 4, 2012 | Compliance, Legal, and Malpractice, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Operations, Laboratory Pathology

Many products that medical laboratories use will be covered under the new UDI system You’re reading it here first! UPCs—universal product codes—are coming soon to the medical laboratory analyzers and other products that your clinical laboratory purchases. Under a proposed rule published by the Food and Drug Administration (FDA), medical devices will soon have UDIs—universal device identifiers. You know about UPCs. Those are the ubiquitous “universal product codes” that are found on literally...

Medical Labs Attacked in India as Part of Ongoing Scope-of-Practice Battle between Pathologists and Medical Laboratory Technologists

Aug 24, 2012 | Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology

India’s courts are slowly addressing scope of practice issues in pathology laboratories Turf wars among medical laboratory professionals about scope of practice—combined with concerns about price-gouging—resulted in the ransacking of three pathology laboratories in India. On Thursday, June 21, 2012, members of the regional political party known as Maharashtra Navnirman Sena (MNS) attacked three pathology laboratories, damaging equipment and furniture. The three medical laboratories were...